Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of 10 citing Costacou: Haptoglobin Genotype. (0.09 sec) 

Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype

- diabetesjournals.org
R Asleh, S Blum, S Kalet-Litman, J Alshiek, R … - Diabetes, 2008 - Am Diabetes Assoc
OBJECTIVE—Pharmacogenomics is a key component of personalized medicine. The
Israel Cardiovascular Events Reduction with Vitamin E Study, a prospective
placebo-controlled study, recently demonstrated that vitamin E could ...
Cited by 14 - Related articles - All 4 versions

Haptoglobin genotype is a major determinant of the amount of iron in the human …

- onlinejacc.org
… , M Purushothaman, P Muntner, NS Levy, V … - Journal of the American College of Cardiology, 2008 - Elsevier
In atherosclerotic lesions, intraplaque hemorrhage releases free hemoglobin
(Hb), whose incorporated iron can act as an oxidant and inflammatory stimulus.
These effects are antagonized by Hp, which binds free Hb and facilitates ...
Cited by 8 - Related articles - All 19 versions

Pharmacogenomic application of the haptoglobin genotype in the prevention of diabetic …


S Blum, U Milman, C Shapira, AP Levy - Pharmacogenomics, 2008 - Future Medicine
The public health and economic burdens from diabetes mellitus (DM) are presently
staggering and are becoming more severe. Morbidity and mortality from DM is due
to the effect of DM on the cardiovascular system. Accelerated ...
Cited by 3 - Related articles - All 3 versions

Haptoglobin: basic and clinical aspects


A Levy, R Asleh, S Blum, N Levy, R Miller- … - Antioxidants & Redox Signaling - liebertonline.com
Haptoglobin is an abundant hemoglobin-binding protein present in the plasma. The
function of haptoglobin is primarily to determine the fate of hemoglobin
released from red blood cells after either intravascular or extravascular ...
Cited by 1 - Related articles - All 3 versions

Pharmacogenomics and the prevention of vascular complications in diabetes mellitus


D Farbstein, AP Levy - Therapy, 2009 - Future Medicine
While the majority of patients benefit from front-line therapies for diabetes
and dyslipidemia, others present with diminished responses. These differences in
drug efficacy appear to be due, in large part, to genetic polymorphisms ...
Cited by 1 - Related articles - All 3 versions

[PDF] Lipoprotein-associated phospholipase A


RG Miller, T Costacou, TJ Orchard - Diabetes & Vascular Disease Research - dvdres.co.uk
Diabetes & Vascular Disease Research 01 –09 © The Author(s) 2009 Reprints and
permission: http://www. sagepub.co.uk/journalsPermission.nav DOI:
10.1177/1479164109346358 http://dvr.sagepub.com
Related articles - View as HTML - All 3 versions

Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after …


KL Chaichana, G Pradilla, J Huang, RJ … - Surgical Neurology, 2009 - Elsevier
There is increasing evidence that inflammation and, more specifically,
leukocyte-endothelial cell interactions play a critical role in the pathogenesis
of vasospasm after aSAH, as well as in other conditions including ...
Related articles - All 2 versions

WITHDRAWN: The Haptoglobin 2-2 genotype is associated with increased redox active …


S Kalet-Litmana, PR Moreno, AP Levya - Atherosclerosis, 2009 - Elsevier
Note to users: The section "Articles in Press" contains peer reviewed accepted
articles to be published in this journal. When the final article is assigned to
an issue of the journal, the "Article in Press" version will be removed ...
Related articles - All 3 versions

Divergent effects of α-tocopherol and vitamin C on the generation of dysfunctional HDL …


R Asleh, A Levy - Antioxidants & Redox Signaling - liebertonline.com
Page 1. Asleh 1 FORUM ORIGINAL RESEARCH COMMUNICATION Divergent effects of
α-tocopherol and vitamin C on the generation of dysfunctional ...
Related articles - All 3 versions

[PDF] Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL …


A Schwartz, S Blum, R Asleh, M Pollak, S … - Pharmacogenomics and Personalized Medicine, 2009 - dovepress.com
© 2009 Schwartz et al, publisher and licensee Dove Medical Press Ltd.This is an
Open Access article which permits unrestricted noncommercial use, provided the
original work is properly cited. ... Avery Schwartz Shany Blum Rabea Asleh ...
Related articles - View as HTML - All 3 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google